Mu Chen is a highly experienced Principal Scientist currently affiliated with Regeneron since April 2023, following a role as Principal Scientist at Bristol Myers Squibb from March 2021 to May 2022, where responsibilities included representing DMPK bioanalytical in cross-functional study teams and supporting IND enabling studies and NDA/BLA filings. Prior experience includes a position as Senior Scientist at Celgene and Group Leader at Frontage Laboratories, where Mu Chen led bioanalytical method development and validation projects for various studies while ensuring regulatory compliance. Mu Chen holds a Ph.D. from Rutgers University and a Bachelor's degree in Chemistry from Nanjing University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices